0001225208-13-014061.txt : 20130606 0001225208-13-014061.hdr.sgml : 20130606 20130606163113 ACCESSION NUMBER: 0001225208-13-014061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130605 FILED AS OF DATE: 20130606 DATE AS OF CHANGE: 20130606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elicker John E CENTRAL INDEX KEY: 0001554788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 13897677 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 4 1 doc4.xml X0306 4 2013-06-05 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001554788 Elicker John E BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 SVP Pub Affairs & Inv Relation Common Stock, $0.10 par value 2013-06-05 4 M 0 19723.0000 17.5100 A 54278.9700 D Common Stock, $0.10 par value 2013-06-05 4 M 0 7377.0000 22.1400 A 61655.9700 D Common Stock, $0.10 par value 2013-06-05 4 M 0 6615.0000 27.0100 A 68270.9700 D Common Stock, $0.10 par value 2013-06-05 4 S 0 25997.0000 46.3300 D 42273.9700 D Option (right to buy) 17.5100 2013-06-05 4 M 0 19723.0000 0.0000 D 2019-03-02 Common Stock, $0.10 par value 19723.0000 0.0000 D Option (right to buy) 22.1400 2013-06-05 4 M 0 7377.0000 0.0000 D 2018-03-03 Common Stock, $0.10 par value 7377.0000 0.0000 D Option (right to buy) 27.0100 2013-06-05 4 M 0 6615.0000 0.0000 D 2017-03-05 Common Stock, $0.10 par value 6615.0000 0.0000 D The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.28 to $46.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007. /s/ Robert J. Wollin, attorney-in-fact for John E. Elicker 2013-06-06